Morgan Stanley’s Pyxis Oncology PYXS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $176K | Sell |
160,174
-286,308
| -64% | -$315K | ﹤0.01% | 5904 |
|
|
2025
Q1 | $438K | Buy |
446,482
+203,751
| +84% | +$200K | ﹤0.01% | 5389 |
|
|
2024
Q4 | $379K | Buy |
242,731
+89,483
| +58% | +$140K | ﹤0.01% | 5540 |
|
|
2024
Q3 | $562K | Buy |
153,248
+70,637
| +86% | +$259K | ﹤0.01% | 5346 |
|
|
2024
Q2 | $273K | Buy |
82,611
+39,084
| +90% | +$129K | ﹤0.01% | 5543 |
|
|
2024
Q1 | $185K | Buy |
43,527
+37,127
| +580% | +$158K | ﹤0.01% | 5762 |
|
|
2023
Q4 | $11.5K | Buy |
6,400
+3,200
| +100% | +$5.76K | ﹤0.01% | 6801 |
|
|
2023
Q3 | $6.37K | Buy |
3,200
+2,700
| +540% | +$5.37K | ﹤0.01% | 6858 |
|
|
2023
Q2 | $1.28K | Sell |
500
-168,076
| -100% | -$430K | ﹤0.01% | 7262 |
|
|
2023
Q1 | $676K | Buy |
168,576
+62,157
| +58% | +$249K | ﹤0.01% | 5080 |
|
|
2022
Q4 | $143K | Sell |
106,419
-15,581
| -13% | -$20.9K | ﹤0.01% | 5812 |
|
|
2022
Q3 | $240K | Sell |
122,000
-14,877
| -11% | -$29.3K | ﹤0.01% | 5642 |
|
|
2022
Q2 | $325K | Buy |
136,877
+133,691
| +4,196% | +$317K | ﹤0.01% | 5640 |
|
|
2022
Q1 | $12K | Buy |
3,186
+354
| +13% | +$1.33K | ﹤0.01% | 7353 |
|
|
2021
Q4 | $31K | Buy |
+2,832
| New | +$31K | ﹤0.01% | 7029 |
|